Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

332 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    外資の研究開発投資が拡大 中国、世界のイノベーション拠点

    外資系企業による中国での研究開発投資が拡大している。今年1〜2月に新設された外資系企業は8631社に上り、前年同期比で14%増加した...
    ChinaGovernment, Public Sector
    Kangxin
    Kangxin
  • Article

    China's Central Government Introduces Major Policy Incentives And Restraints To The MedTech Industry

    After continuously reshaping the competitive landscape in the pharmaceutical industry for several years, the Chinese government finally shifted its attention to the medtech industry.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
Article

China Aims To Introduce Routine Drug And Device Overseas Inspections

China's drug and device regulator recently announced a set of rules signaling increased scrutiny of foreign drug and device companies.
ChinaFood, Drugs, Healthcare, Life Sciences
Ropes & Gray LLP
Ropes & Gray LLP
  • Article

    China FDA Announces Good Clinical Practices For Medical Devices

    On March 23, 2016, the China Food and Drug Administration ("CFDA") and the National Health and Family Planning Commission jointly promulgated the final revision to the 2004 Medical Device Clinical Studies Rules...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China Life Sciences Compliance Update: Kickback And Third-Party Case Study

    A recent criminal judgment published by the Gao'an People's Court in Jiangxi province (江西省高安市人民法院) in June 2025 has drawn public attention to Jiangxi Baishen Pharmaceutical Co.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    China Signs Off On PRC Biosecurity Law: What This Means For Industry Players In China

    On 17 October 2020, the Standing Committee of the PRC National People's Congress passed the PRC Biosecurity law, which will become effective on April 15, 2021
    ChinaFood, Drugs, Healthcare, Life Sciences
    DLA Piper
    DLA Piper
  • Article

    China Solicits Comments On Post-Market Study Guidelines

    The Center for Drug Evaluation ("CDE") in China recently published the draft Guidelines for the Administration of Post-Market Studies on Chemical Drugs and Therapeutic Biologics ("Draft Guidelines") for public comments through November 21, 2013.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    HHS Launches Operation TrialBlazer To Advance US Clinical Research Leadership

    The US Department of Health and Human Services has launched Operation TrialBlazer to address China's growing dominance in clinical research and restore American leadership in biomedical innovation. As Chinese clinical trials now surpass US trials in both speed and volume, this comprehensive initiative aims to modernize regulatory processes, reduce administrative burdens, and reverse the trend of research investment flowing overseas.
    ChinaFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Schulte
    McDermott Will & Schulte
  • Article

    Pharma Investigations Show New Trends In Commercial Bribery Enforcement

    A number of recent commercial bribery cases concerning multinational pharmaceutical companies have drawn extensive attention.
    ChinaFood, Drugs, Healthcare, Life Sciences
    DaHui Lawyers
    DaHui Lawyers
  • Article

    New Regulations Promote Drug Patent Linkage System

    These documents provide specific operational guidelines for the newly established early settlement mechanism for drug patent disputes.
    ChinaIntellectual Property
    AFD China
    AFD China
  • Article

    Roche Winning The Reagent Kit Patent Infringement Case In Shanghai

    Since it was founded in 1896, Roche has grown decade upon decade into a world-leading healthcare company, focused on developing medicines and diagnostics to help patients live longer, better lives.
    ChinaIntellectual Property
    China Sinda Intellectual Property Ltd
    China Sinda Intellectual Property Ltd
  • Article

    北京知识产权法院审理全国首例药品专利链接诉讼案件

    北京知识产权法院审理全国首例药品专利链接诉讼案件.
    ChinaIntellectual Property
    Rouse
    Rouse
  • Article

    중국 최고인민검찰원, 위조품 제조 및 판매죄 처벌의 대표적 사례 공개

    2022년 3월 14일, 중국 최고인민검찰원(最高人民检察院)...
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    중국 약과대학 등, '전국 바이오의약 산업 지식재산권 보호 연맹' 설립

    2023년 10월 10일, 중국약과대학 등 10개 주체가 ‘전국 바이오의약 산업 지식재산권 보호 연맹'을 설립했다고 중국 지식산권망(CNIPR)이 보도함
    ChinaLitigation, Mediation & Arbitration
    Kangxin
    Kangxin
  • Article

    China Tightens Food Safety Administration

    The Chinese State Council recently announced the draft amendment of the Food Safety Law ("Draft Amendment") for public comments through November 29, 2013
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China Patent Eligibility Update: Human Embryonic Stem Cells

    On September 23, 2019, China National Intellectual Property Administration ("CNIPA") announced its proposed amendments to China's Guideline on Patent Examination (the "Guideline"), ...
    ChinaIntellectual Property
    Morrison Foerster
    Morrison Foerster
  • Article

    China Aims To Tighten Supervision Over Clinical Studies

    China’s health authority, the National Health and Family Planning Commission, released the Administrative Measures for the Clinical Study Projects of Medical Institutions.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China Life Sciences Compliance Update: Insurance Fraud Enforcement Campaign And New Ethical Code For HCPs

    Chinese authorities have launched a special "Hundred-Day Campaign" to target misconduct relating to China's state-run medical insurance program and issued a new Ethical Code for Healthcare Professionals...
    ChinaFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Survival Of The Fittest Or Cheapest?

    T he past year is set to be a milestone year for China's pharmaceutical regulatory reform as the newly formed National Medical Products Administration (NMPA) continues to aggressively cut back on red
    ChinaFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    Technicians Appointed To Advise On IP Cases

    A total of 115 technicians were appointed as investigators by Beijing Intellectual Property Court in February to help solve technical cases.
    ChinaFood, Drugs, Healthcare, Life Sciences
    AFD China
    AFD China
  • Showing 61–80 of 332 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics